Microbio Co., Ltd. (TPEX:4128)
17.15
-0.60 (-3.38%)
Apr 17, 2026, 1:30 PM CST
Microbio Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 711.13 | 673.28 | 617.04 | 1,132 | 725.71 |
Short-Term Investments | 1,825 | 1,755 | 2,815 | 2,757 | 3,187 |
Trading Asset Securities | 94.39 | 123.74 | 204.58 | 188.72 | 119.56 |
Cash & Short-Term Investments | 2,630 | 2,552 | 3,637 | 4,078 | 4,032 |
Cash Growth | 3.04% | -29.81% | -10.82% | 1.14% | -3.30% |
Accounts Receivable | 43.96 | 268.97 | 53.66 | 66.75 | 68.73 |
Other Receivables | 309.32 | 36.46 | 32.78 | 29.3 | 14.82 |
Receivables | 353.28 | 305.42 | 86.45 | 96.05 | 83.55 |
Inventory | 260.99 | 222.12 | 198.69 | 222.45 | 216.55 |
Other Current Assets | 161.84 | 55.77 | 89.41 | 60.1 | 153.41 |
Total Current Assets | 3,406 | 3,136 | 4,011 | 4,457 | 4,486 |
Property, Plant & Equipment | 1,737 | 1,824 | 1,858 | 1,773 | 1,851 |
Long-Term Investments | 6,823 | 8,492 | 8,382 | 8,367 | 8,186 |
Goodwill | 39.41 | 39.41 | 39.41 | 39.41 | 39.41 |
Other Intangible Assets | 110.64 | 138.61 | 140.84 | 163.93 | 182.59 |
Long-Term Deferred Tax Assets | 6.2 | 6.23 | 6.09 | 5.91 | 5.68 |
Other Long-Term Assets | 211.05 | 290.69 | 297.88 | 284.44 | 265.96 |
Total Assets | 12,334 | 13,927 | 14,735 | 15,091 | 15,017 |
Accounts Payable | 175.05 | 141.9 | 166.26 | 122.48 | 129.14 |
Accrued Expenses | 124.9 | 114.27 | 107.68 | 118.13 | 122.19 |
Current Portion of Leases | 146.39 | 147.18 | 140.36 | 117.01 | 117.5 |
Current Unearned Revenue | 273.6 | 70.01 | 18.34 | 20.22 | 20.4 |
Other Current Liabilities | 72.05 | 62.49 | 60.46 | 66.09 | 112.15 |
Total Current Liabilities | 791.99 | 535.85 | 493.1 | 443.93 | 501.37 |
Long-Term Leases | 520.81 | 468.55 | 478.8 | 370.81 | 400.07 |
Long-Term Unearned Revenue | 746.09 | 986.83 | 194.96 | 198.61 | 195.73 |
Pension & Post-Retirement Benefits | 52.47 | 52.55 | 56.35 | 57.48 | 63.95 |
Long-Term Deferred Tax Liabilities | 4.25 | 3.97 | 3.56 | 3.97 | 4.17 |
Other Long-Term Liabilities | 13.72 | 10.19 | 7.92 | 7.62 | 7.76 |
Total Liabilities | 2,129 | 2,058 | 1,235 | 1,082 | 1,173 |
Common Stock | 5,882 | 5,882 | 5,602 | 5,111 | 4,663 |
Additional Paid-In Capital | 3,933 | 4,980 | 6,373 | 5,736 | 6,180 |
Retained Earnings | -735.57 | -1,075 | -1,124 | 248.68 | 49.98 |
Treasury Stock | - | - | - | - | -103.57 |
Comprehensive Income & Other | -165.94 | 518.92 | 960.67 | 997.69 | 1,104 |
Total Common Equity | 8,914 | 10,306 | 11,811 | 12,093 | 11,894 |
Minority Interest | 1,291 | 1,564 | 1,689 | 1,915 | 1,950 |
Shareholders' Equity | 10,204 | 11,869 | 13,500 | 14,008 | 13,844 |
Total Liabilities & Equity | 12,334 | 13,927 | 14,735 | 15,091 | 15,017 |
Total Debt | 667.2 | 615.73 | 619.16 | 487.82 | 517.57 |
Net Cash (Debt) | 1,963 | 1,937 | 3,018 | 3,590 | 3,515 |
Net Cash Growth | 1.35% | -35.82% | -15.95% | 2.16% | -4.17% |
Net Cash Per Share | 3.34 | 3.29 | 5.13 | 6.11 | 6.13 |
Filing Date Shares Outstanding | 588.17 | 588.17 | 588.17 | 588.17 | 578.11 |
Total Common Shares Outstanding | 588.17 | 588.17 | 588.17 | 588.17 | 578.11 |
Working Capital | 2,614 | 2,600 | 3,518 | 4,013 | 3,984 |
Book Value Per Share | 15.15 | 17.52 | 20.08 | 20.56 | 20.57 |
Tangible Book Value | 8,764 | 10,128 | 11,631 | 11,890 | 11,672 |
Tangible Book Value Per Share | 14.90 | 17.22 | 19.77 | 20.21 | 20.19 |
Land | 294.89 | 351.21 | 351.21 | 351.21 | 351.21 |
Buildings | 798.67 | 863.8 | 840.8 | 847.66 | 790.18 |
Machinery | 697.42 | 685.99 | 663.68 | 662.74 | 656.92 |
Construction In Progress | 2.47 | 1.8 | 16.49 | 4.32 | 47.39 |
Leasehold Improvements | 198.67 | 183.61 | 177.07 | 162.49 | 155.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.